What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association

Background According to the World Health Organization (WHO) the cost of adverse drug reactions   (ADRs) in the general population is high and under-reporting by health professionals   is a well-recognized problem. Another way to increase ADR reporting is to let the   consumers themselves report directly to the authorities. In Sweden it is mandatory   for prescribers to report serious ADRs to the Medical Products Agency (MPA), but there   are no such regulations for consumers. The non-profit and independent organization   Consumer Association for Medicines and Health, KILEN has launched the possibility   for consumers to report their perceptions and experiences from their use of medicines   in order to strengthen consumer rights within the health care sector. This study aimed   to analyze these consumer reports. Methods All reports submitted from January 2002 to April 2009 to an open web site in Sweden   where anyone could report their experience with the use of pharmaceuticals were analyzed   with focus on common psychiatric side effects related to antidepressant usage. More   than one ADR for a specific drug could be reported. Results In total 665 reports were made during the period. 442 reports concerned antidepressant   medications and the individual antidepressant reports represented 2392 ADRs and 878   (37%) of these were psychiatric ADRs. 75% of the individual reports concerned serotonin-reuptake   inhibitor (SSRI) and the rest serotonin-norepinephrine reuptake inhibitor (SNRI).   Women reported more antidepressant psychiatric ADRs (71%) compared to men (24%). More   potentially serious psychiatric ADRs were frequently reported to KILEN and withdrawal   symptoms during discontinuation were also reported as a common issue. Conclusions The present study indicates that consumer reports may contribute with important information   regarding more serious psychiatric ADRs following antidepressant treatment. Consumer   reporting may be considered a complement to traditional ADR reporting

Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly?

<p>Abstract</p> <p>Background</p> <p>While antidepressant-induced suicidality is a concern in younger age groups, there is mounting evidence that these drugs may reduce suicidality in the elderly. Regarding a possible association between other types of psychoactive drugs and suicide, results are inconclusive. Sedatives and hypnotics are widely prescribed to elderly persons with symptoms of depression, anxiety, and sleep disturbance. The aim of this case-control study was to determine whether specific types of psychoactive drugs were associated with suicide risk in late life, after controlling for appropriate indications.</p> <p>Methods</p> <p>The study area included the city of Gothenburg and two adjacent counties (total 65+ population 210 703 at the start of the study). A case controlled study of elderly (65+) suicides was performed and close informants for 85 suicide cases (46 men, 39 women mean age 75 years) were interviewed by a psychiatrist. A population based comparison group (n = 153) was created and interviewed face-to-face. Primary care and psychiatric records were reviewed for both suicide cases and comparison subjects. All available information was used to determine past-month mental disorders in accordance with DSM-IV.</p> <p>Results</p> <p>Antidepressants, antipsychotics, sedatives and hypnotics were associated with increased suicide risk in the crude analysis. After adjustment for affective and anxiety disorders neither antidepressants in general nor SSRIs showed an association with suicide. Antipsychotics had no association with suicide after adjustment for psychotic disorders. Sedative treatment was associated with an almost fourteen-fold increase of suicide risk in the crude analyses and remained an independent risk factor for suicide even after adjustment for any DSM-IV disorder. Having a current prescription for a hypnotic was associated with a four-fold increase in suicide risk in the adjusted model.</p> <p>Conclusion</p> <p>Sedatives and hypnotics were both associated with increased risk for suicide after adjustment for appropriate indications. Given the extremely high prescription rates, a careful evaluation of the suicide risk should always precede prescribing a sedative or hypnotic to an elderly individual.</p

Monitoring of IVF birth outcomes in Finland: a data quality study

BACKGROUND: The collection of information on infertility treatments is important for the surveillance of potential health consequences and to monitor service provision. STUDY DESIGN: We compared the coverage and outcomes of IVF children reported in aggregated IVF statistics, the Medical Birth Register (subsequently: MBR) and research data based on reimbursements for IVF treatments in Finland in 1996–1998. RESULTS: The number of newborns were nearly equal in the three data sources (N = 4331–4384), but the linkage between the MBR and the research data revealed that almost 40% of the reported IVF children were not the same individuals. The perinatal outcomes in the three data sources were similar, excluding the much lower incidence of major congenital anomalies in the IVF statistics (157/10 000 newborns) compared to other sources (409–422/10 000 newborns). CONCLUSION: The differences in perinatal outcomes in the three data sets were in general minor, which suggests that the observed non-recording in the MBR is most likely unbiased

Feasibility of a controlled trial aiming to prevent excessive pregnancy-related weight gain in primary health care

<p>Abstract</p> <p>Background</p> <p>Excessive gestational weight gain and postpartum weight retention may predispose women to long-term overweight and other health problems. Intervention studies aiming at preventing excessive pregnancy-related weight gain are needed. The feasibility of implementing such a study protocol in primary health care setting was evaluated in this pilot study.</p> <p>Methods</p> <p>A non-randomized controlled trial was conducted in three intervention and three control maternity and child health clinics in primary health care in Finland. Altogether, 132 pregnant and 92 postpartum women and 23 public health nurses (PHN) participated in the study. The intervention consisted of individual counselling on physical activity and diet at five routine visits to a PHN and of an option for supervised group exercise until 37 weeks' gestation or ten months postpartum. The control clinics continued their usual care. The components of the feasibility evaluation were 1) recruitment and participation, 2) completion of data collection, 3) realization of the intervention and 4) the public health nurses' experiences.</p> <p>Results</p> <p>1) The recruitment rate was slower than expected and the recruitment period had to be prolonged from the initially planned three months to six months. The average participation rate of eligible women at study enrolment was 77% and the drop-out rate 15%. 2) In total, 99% of the data on weight, physical activity and diet and 96% of the blood samples were obtained. 3) In the intervention clinics, 98% of the counselling sessions were realized, their contents and average durations were as intended, 87% of participants regularly completed the weekly records for physical activity and diet, and the average participation percentage in the group exercise sessions was 45%. 4) The PHNs regarded the extra training as a major advantage and the high additional workload as a disadvantage of the study.</p> <p>Conclusion</p> <p>The study protocol was mostly feasible to implement, which encourages conducting large trials in comparable settings.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN21512277</p

Drug related deaths in the Nordic countries : Revision of the statistical definition

Recently the official statistics describing drug related deaths in Sweden werescrutinised. One of the most important findings was that statistical trend data ofdrug related deaths in Sweden was not comparable over time. The main reasonsbehind this being changes in coding practices and in methods used in forensicchemistry. As a result the national Swedish index was revised. It is within thatcontext the revision of the NOMESCO-index should be seen.In the process of investigating the topic at hand other related issues has emerged,such as the definition of the present index and the implementation of the same

Health and health care of the elderly in the Nordic Countries : From a statistical perspective

The Nordic region has one of the world’s oldest populations and over the past decades, the health and care of elderly people have attracted more and more attention, as the proportion of elderly people in the population is increasing. This trend is expected to continue in the coming decades. The aim of this report is to provide a general statistical description of the care and treatment of elderly people in the Nordic region from the age of 65, with a focus on the 80+ age group. Another aim is to develop and improve NOMESCO’s annual statistics, and revisions to the statistics are proposed where necessary. Some of the OECD indicators are used to highlight and compare certain aspects of health care that are particularly important for elderly people. The report is based on available Nordic statistics collected continually by NOMESCO and other international organisations, and on statistics collected especially for this project from the national patient, cancer, prescribed drugs, and cause of death registers. The statistics show, for example, the occurrence of disease, pharmaceutical prescriptions and mortality in different age groups over 65, distinguishing between women and men, in the Nordic countries. Most of the data is from 2015. Information from national interview surveys is an important complement to the registry data, enabling health trends in the population to be monitored over time. Over several decades, the Nordic countries have developed their own surveys of living conditions, which are adapted to national circumstances. This means there are certain differences between the countries in survey methods and degree of coverage

NOMESCO Classification of Surgical Procedures (NCSP), version 1.16

This book gives an overview of the NCSP codes. Moreover it gives information on the NCSP update routine, which can be found in the section on Structure and classification guidelines

Medicines Consumption in the Nordic Countries 1999-2003

In 2004, NOMESCO received funding from the Nordic Council of Ministers for a special publication concerning medicines consumption and expenditure. The report is a follow-up to the theme section of Health Statistics in the Nordic Countries 1999. NOMESCO 61:2001.   Chapter 1 highlights the general trends and regulatory changes during 1999-2003. Chapter 2 provides an account of the structure of the report. Chapter 3 and 4 describe the development of medicines expenditure and the development of medicines consumption, respectively.

Health Statistics for the Nordic Countries 2011

In this publication NOMESCO presents the latest available data from the health statistics of the Nordic countries. The book covers the following: Organization of health services; Population and fertility; Morbidity, medical treatment, accidents and medicine; Mortality and causes of death; Resources within the health services, including expenditure, health personnel, capacity and services at hospitals